Xanthelasma palpebrarum-clinical and biochemical profile in a tertiary care hospital of Delhi

Indian Journal of Clinical Biochemistry

Volumn 22, Issue 2, 2007, Pages 151-153

  Jain, Anju ^a   Goyal, P ^a   Nigam, P K ^a   Gurbaksh, H ^a   Sharma, R C ^a  

^a LADY HARDINGE MEDICAL COLLEGE   (India)

Author keywords

Hyperlipidemia; Lipids; Xanthelasma palpebrarum

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; BLOOD ANALYSIS; CHEMICAL ANALYSIS; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE ASSOCIATION; EYELID XANTHELASMA; FEMALE; HUMAN; INDIA; MAJOR CLINICAL STUDY; MALE; TERTIARY HEALTH CARE; XANTHOMA;

EID: 36849002530     PISSN: 09701915     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02913335     Document Type: Article

References (20)

1. Bergam R. The pathogenesis and clinical significance of Xanthelasma Palpebrarum. J Am Acad Dermatol 1994 Feb; 30(2 Pt 1): 236-42.
2. Reddy SN B, Singh G, Pandey SS, Tiwari D. Clinical and lipid profile studies in Xanthelasma Palpebrarum. I J D V L 1983; 49(3): 127-31.
3. Chhetri MK, Chowdhary ND, De B. Xanthelasma Palpebrarum. J Asso Phy Ind 1967; 15(9): 405-12.
4. . Gangopadhyay BN, Dey SK, Mitra C, Pal D, Chaudhuri. Serum lipid profile in Xanthelasma Palpebrarum. Ind J Dermatol 1998; 43(2): 53-7.
5. Vacca JB , William AK, Broun GO. Clinical observations regarding xanthelasma. Ann Int Med 1959; 51: 1019-31.
6. Segal P, Insull W Jr, Chambless LE, Stinnett S, LaRosa JC, Weissfeld L, et al. The association of dyslipoproteinemia with corneal arcus and xanthelasma. The Lipid Research Clinics Program Prevalence Study. Circulation 1987; 73(1 Pt 2): 1108-18.
7. Wolff Eugene .Xanthelasma Palpebrarum. Tumor of sebaceous glands. Br J Dermatol 1951; 63: 296-302.
8. Thompson JA .Xanthelasma associated with throtoxicosis. J Clin Endocr 1965; 25: 758-60.
9. Scott J, Winterbourn CC. Low- density lipoprotein accumulation in actively growing xanthomas. J Atheroscl Res 1967; 7: 207-23.
10. Bergman R, Kasif Y, Aviram M, Maor I, Ullman Y, Gdal OM, et al. Normolipidemic xanthelasma palpebrarum: lipid composition, cholesterol metabolism in monocyte derived macrophages and plasma lipid peroxidation. Acta Derm Venereol 1996; 76(2): 107-10.
11. Marcelo GH, Janis PM. Xanthelasma. 2005 May 12. Available from:URL: eMedicine Specialties
12. Watanabe A, Yoshimura A, Wakasugi T, Tatami R, Ueda K, Ueda R, et al. Serum lipids, lipoprotein lipids and coronary heart disease in patients with xanthelasma palpebrarum. Atherosclerosis 1981; 38(3-4): 283-90.
13. Allain CC, Poon LS, Chan CS, Richmond W, Fu PC. Enzymatic determination of serum cholesterol. Clin Chem 1974; 20: 470.
14. Buccolo G, David H.Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 1973; 19: 476-82.
15. Jonson A, Sigfusson N. Letter: Significance of xanthelasma palpebrarum in normal population. Lancet 1976; 1: 372.
16. Ribera M , Pinto X, Argimon JM, Fiol C, Pujol R, Ferrandiz C. Lipid metabolism and apolipoprotein E phenotypes in patients with xanthelasma. Am J Med 1995; 99(5): 485-90.
17. Pedace FJ, Winkelmann RK. Xanthelasma Palpebrarum. J A M A 1965; 13: 893-4.
18. Dean FD. Xanthelasma and hyperproteinemia. Clinica Chimica Acta 1976; 66(2): 189-93.
19. Tracey A Schmucker, Hampton Roy. Xanthelasma. 2006 May 17. Available from: URL: eMedicine Specialties
20. Farmer JA, Gotto AM Jr. The Heart Protection Study: expanding the boundaries for high-risk coronary disease prevention. Am J Cardiol 2003; 92(1A): 3i-9i.